SCM
AMED

Sterling Capital Management’s Amedisys AMED Stock Holding History

Sterling Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,174
Closed -$214K – 3245
2025
Q2 		$214K Buy
2,174
+366
+20% +$34.6K ﹤0.01% 1245
2025
Q1 		$167K Sell
1,808
-114
-6% -$10.5K ﹤0.01% 1227
2024
Q4 		$174K Buy
1,922
+648
+51% +$59.5K ﹤0.01% 1308
2024
Q3 		$123K Buy
+1,274
New +$124K ﹤0.01% 1362
2019
Q3 		$1.95M Buy
14,875
+1,951
+15% +$254K 0.02% 417
2019
Q2 		$1.57M Hold
12,924
– – 0.02% 458
2019
Q1 		$1.59M Sell
12,924
-5,113
-28% -$642K 0.02% 442
2018
Q4 		$2.11M Hold
18,037
– – 0.02% 371
2018
Q3 		$2.25M Sell
18,037
-5,727
-24% -$632K 0.02% 396
2018
Q2 		$2.03M Hold
23,764
– – 0.02% 403
2018
Q1 		$1.43M Buy
+23,764
New +$1.35M 0.01% 491
2017
Q4 		– Sell
-16,654
Closed -$932K – 879
2017
Q3 		$932K Buy
16,654
+2,268
+16% +$120K 0.01% 642
2017
Q2 		$903K Sell
14,386
-11,558
-45% -$673K 0.01% 636
2017
Q1 		$1.33M Sell
25,944
-3,903
-13% -$186K 0.01% 487
2016
Q4 		$1.27M Buy
29,847
+9,076
+44% +$386K 0.01% 498
2016
Q3 		$985K Sell
20,771
-4,860
-19% -$243K 0.01% 531
2016
Q2 		$1.29M Sell
25,631
-2,570
-9% -$130K 0.01% 475
2016
Q1 		$1.36M Buy
+28,201
New +$1.09M 0.01% 458
2014
Q3 		– Sell
-27,946
Closed -$468K – 888
2014
Q2 		$468K Buy
27,946
+724
+3% +$10.3K ﹤0.01% 742
2014
Q1 		$405K Buy
27,222
+737
+3% +$11.3K ﹤0.01% 806
2013
Q4 		$387K Buy
26,485
+2,062
+8% +$33.2K ﹤0.01% 666
2013
Q3 		$420K Buy
+24,423
New +$362K ﹤0.01% 453

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Sterling Capital Management's AMED Position: Q3 2025 in Review

Sterling Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 2,174 shares — an estimated $214K sold.

Sterling Capital Management first reported a position in AMED in Q3 2013 and held it in 22 quarters. The position peaked at $2.25M in Q3 2018. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Sterling Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Sterling Capital Management sold 2,174 Amedisys shares in Q3 2025, an estimated $214K.
  • Sterling Capital Management first reported a position in Amedisys in Q3 2013 and held it in 22 quarters.
  • Sterling Capital Management's Amedisys position peaked at $2.25M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Sterling Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.